We are live on
!
Find out more
MC
Mathes Company Portfolio holdings
AUM
$274M
1-Year Est. Return
33.72%
This Fund
S&P 500
This Quarter
Est. Return
+4.16%
1 Year Est. Return
+33.72%
3 Year Est. Return
+105.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$274M
AUM Growth
-$9.44M
(-3.3%)
Cap. Flow
-$18.1M
Cap. Flow
% of AUM
-6.6%
Top 10 Holdings %
Top 10 Hldgs %
36.68%
Holding
129
New
2
Increased
8
Reduced
53
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$3.61M |
| 2 |
Eli Lilly
LLY
|
+$464K |
| 3 |
Trade Desk
TTD
|
+$247K |
| 4 |
BlackRock Capital Allocation Term Trust
BCAT
|
+$214K |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$109K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.54M |
| 2 |
SLY
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
|
+$2.12M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$2.03M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.35M |
| 5 |
iShares Expanded Tech Sector ETF
IGM
|
+$1.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.87% |
| 2 | Industrials | 15.07% |
| 3 | Financials | 7.41% |
| 4 | Communication Services | 5.78% |
| 5 | Consumer Staples | 5.38% |
Similar funds
SN
BWM
OL
JWM
MP
ORAM
3C
SCM
Mathes Company's Q4 2024 Portfolio in Review
As of Q4 2024, Mathes Company held 129 positions worth $274M, down 3.3% from $283M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Mathes Company withdrew a net $18.1M in Q4 2024, closing 5 positions and reducing 53 holdings. Its most notable exit was Novo Nordisk, an estimated $499K position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Financials.
Against the trend, Mathes Company opened a new position in Eli Lilly worth $432K.
- Mathes Company's largest Q4 2024 buy was Eli Lilly: 560 shares worth $432K.
- Mathes Company added most to Procter & Gamble in Q4 2024, an estimated $3.61M increase.
- Mathes Company's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $2.54M.
- Mathes Company fully exited Novo Nordisk in Q4 2024, selling an estimated $499K.
- Mathes Company's ten largest holdings make up 37% of its $274M portfolio in Q4 2024.
- Mathes Company opened 2 new positions and closed 5 in Q4 2024.
- Mathes Company's portfolio value fell 3.3% quarter-over-quarter to $274M.
Based on Mathes Company's 13F filing for Q4 2024, filed 31 Jan 2025.